Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 28 September 1984:
Vol. 225. no. 4669, pp. 1473 - 1476
DOI: 10.1126/science.6089348

Articles

Science, Vol 225, Issue 4669, 1473-1476
Copyright © 1984 by American Association for the Advancement of Science


articles

Human T-cell leukemia virus (HTLV-I) antibodies in Africa

W Saxinger, WA Blattner, PH Levine, J Clark, R Biggar, M Hoh, J Moghissi, P Jacobs, L Wilson, R Jacobson, and al. et

Antibodies specific for human T-cell leukemia-lymphoma virus type I (HTLV-I) were demonstrated in serum samples from various groups of people in South Africa, Uganda, Ghana, Nigeria, Tunisia, and Egypt. The samples had been collected for other purposes and were presumably selected without bias toward clinical conditions associated with HTLV infections. Regional differences in antibody positivity were observed, indicating widely distributed loci of occurrence of HTLV on the African continent in people of both black and white ancestry. Two patients with high titers of antibody to HTLV-I had some signs of adult T-cell leukemia-lymphoma. In several groups a high frequency of false positive serum reactions was indicated when specific confirmation steps were included in the assay. Further characterization of these sera revealed highly elevated immunoglobulin levels, possibly due to polyclonal activation of immunoglobulin synthesis in these subjects. The possibility that related cross-reactive human retroviruses coexist in the same groups was not eliminated.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Loss of correlation between HIV viral load and CD4+ T-cell counts in HIV/HTLV-1 co-infection in treatment naive Mozambican patients.
N B Bhatt, E S Gudo, C Sema, D Bila, P Di Mattei, O Augusto, R Garsia, and I V Jani (2009)
Int J STD AIDS 20, 863-868
   Abstract »    Full Text »    PDF »
Expression of Glucose Transporter 1 Confers Susceptibility to Human T-Cell Leukemia Virus Envelope-Mediated Fusion.
A. K. Coskun and R. E. Sutton (2005)
J. Virol. 79, 4150-4158
   Abstract »    Full Text »    PDF »
Human T-Cell Lymphotropic Virus Type 1 Gag Indeterminate Western Blot Patterns in Central Africa: Relationship to Plasmodium falciparum Infection.
R. Mahieux, P. Horal, P. Mauclere, O. Mercereau-Puijalon, M. Guillotte, L. Meertens, E. Murphy, and A. Gessain (2000)
J. Clin. Microbiol. 38, 4049-4057
   Abstract »    Full Text »    PDF »
Human T-Lymphocyte Transformation with Human T-Cell Lymphotropic Virus Type 2.
S. L. Tarsis, M.-T. Yu, E. S. Parks, D. Persaud, J. L. Munoz, and W. P. Parks (1998)
J. Virol. 72, 841-846
   Abstract »    Full Text »    PDF »
Treatment of Adult T-Cell Leukemia-Lymphoma with a Combination of Interferon Alfa and Zidovudine.
P. S. Gill, W. Harrington, M. H. Kaplan, R. C. Ribeiro, J. M. Bennett, H. A. Liebman, M. Bernstein-Singer, B. M. Espina, L. Cabral, S. Allen, et al. (1995)
N. Engl. J. Med. 332, 1744-1748
   Abstract »    Full Text »    PDF »
Pathogenesis of Diseases Induced by Human Lymphotropic Virus Type I Infection.
P. Hollsberg and D. A. Hafler (1993)
N. Engl. J. Med. 328, 1173-1182
   Full Text »
The Impact of Human T-Lymphotrophic Virus Type I/II Infection on the Prognosis of Sexually Acquired Cases of Acquired Immunodeficiency Syndrome.
E. Gotuzzo, J. Escamilla, I. A. Phillips, J. Sanchez, F. S. Wignall, and J. Antigoni (1992)
Arch Intern Med 152, 1429-1432
   Abstract »    PDF »
Adult T-Cell Leukemia/Lymphoma in Brooklyn.
H. Dosik, S. Denic, N. Patel, M. Krishnamurthy, P. H. Levine, and J. W. Clark (1988)
JAMA 259, 2255-2257
   Abstract »    PDF »
The Many Epidemiological Faces of AIDS With Special Reference to Hong Kong and Implications for Prevention and Control.
K. Thong (1987)
Asia Pac J Public Health 1, 17-23
   Abstract »    PDF »
Transmission of HTLV-I and HIV Among Homosexual Men in Trinidad.
C. Bartholomew, W. C. Saxinger, J. W. Clark, M. Gail, A. Dudgeon, B. Mahabir, B. Hull-Drysdale, F. Cleghorn, R. C. Gallo, and W. A. Blattner (1987)
JAMA 257, 2604-2608
   Abstract »    PDF »
AIDS in Africa: an epidemiologic paradigm.
T. Quinn, J. Mann, J. Curran, and P Piot (1986)
Science 234, 955-963
   Abstract »    PDF »
Expression of the pX gene of HTLV-I: general splicing mechanism in the HTLV family.
M Seiki, A Hikikoshi, T Taniguchi, and M Yoshida (1985)
Science 228, 1532-1534
   Abstract »    PDF »
Evidence for exposure to HTLV-III in Uganda before 1973.
W. Saxinger, P. Levine, A. Dean, G de The, G Lange-Wantzin, J Moghissi, F Laurent, M Hoh, M. Sarngadharan, and R. Gallo (1985)
Science 227, 1036-1038
   Abstract »    PDF »
Diagnostic potential for human malignancies of bacterially produced HTLV-I envelope protein.
K. Samuel, J. Lautenberger, C. Jorcyk, S Josephs, F Wong-Staal, and T. Papas (1984)
Science 226, 1094-1097
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)